These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16893502

  • 21. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model.
    Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D.
    J Am Soc Nephrol; 2007 Feb; 18(2):528-38. PubMed ID: 17202414
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
    Rosón MI, Cao G, Della Penna S, Gorzalczany S, Pandolfo M, Toblli JE, Fernández BE.
    Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
    [Abstract] [Full Text] [Related]

  • 23. FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.
    Ni HF, Chen JF, Zhang MH, Pan MM, Zhang JD, Liu H, Tang RN, Ma KL, Liu BC.
    Ren Fail; 2013 Aug; 35(7):996-1004. PubMed ID: 23848241
    [Abstract] [Full Text] [Related]

  • 24. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T, Yin KS, Liu KY, Lu GJ, Li YH, Chen JD.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2312-9. PubMed ID: 19080339
    [Abstract] [Full Text] [Related]

  • 25. Peritubular capillary loss is ameliorated by ramipril or valsartan treatment.
    Zhang B, Chen N, Shi W, Wang W, Shi H, Yu H.
    Microcirculation; 2008 May 20; 15(4):337-48. PubMed ID: 18464162
    [Abstract] [Full Text] [Related]

  • 26. A re-evaluation of the renal ablation model of progressive renal disease in rats.
    Kim KH, Kim Y, Park HW, Jeong HJ, Mauer M.
    J Nephrol; 2003 May 20; 16(2):196-202. PubMed ID: 12768066
    [Abstract] [Full Text] [Related]

  • 27. Role of connective tissue growth factor in experimental radiation nephropathy in rats.
    Liu DG, Wang TM.
    Chin Med J (Engl); 2008 Oct 05; 121(19):1925-31. PubMed ID: 19080126
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats.
    Bautista-García P, Sánchez-Lozada LG, Cristóbal-García M, Tapia E, Soto V, Avila-Casado MC, Márquez-Velasco R, Bojalil R, Franco M, Herrera-Acosta J.
    Nephrol Dial Transplant; 2006 Nov 05; 21(11):3074-81. PubMed ID: 16935907
    [Abstract] [Full Text] [Related]

  • 31. [The key role of tubulointerstitium remodeling in progression of chronic renal diseases].
    Mukhin NA, Kozlovskaia LV, Bobkova IN, Rameev VV, Chebotareva NB, Plieva OK, Shcherbak AV, Varshavskiĭ VA, Golitsina EP.
    Arkh Patol; 2004 Nov 05; 66(6):16-22. PubMed ID: 15648161
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B.
    J Pharmacol Exp Ther; 2007 Oct 05; 323(1):85-93. PubMed ID: 17636006
    [Abstract] [Full Text] [Related]

  • 34. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.
    Transplantation; 2007 Dec 15; 84(11):1492-9. PubMed ID: 18091526
    [Abstract] [Full Text] [Related]

  • 35. Potassium citrate administration ameliorates tubulointerstitial lesions in rats with uric acid nephropathy.
    Toblli JE, DeRosa G, Lago N, Angerosa M, Nyberg C, Pagano P.
    Clin Nephrol; 2001 Jan 15; 55(1):59-68. PubMed ID: 11200869
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model.
    Kelly DJ, Zhang Y, Gow R, Gilbert RE.
    J Am Soc Nephrol; 2004 Oct 15; 15(10):2619-29. PubMed ID: 15466266
    [Abstract] [Full Text] [Related]

  • 38. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
    Liu L, Zhao SP, Zhou HN, Li QZ, Li JX.
    J Cardiovasc Pharmacol; 2007 Jul 15; 50(1):50-5. PubMed ID: 17666915
    [Abstract] [Full Text] [Related]

  • 39. An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy.
    Oldroyd SD, Miyamoto Y, Moir A, Johnson TS, El Nahas AM, Haylor JL.
    Am J Physiol Renal Physiol; 2006 Mar 15; 290(3):F695-702. PubMed ID: 16204415
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.